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Significance: This systematic review provides clear evidence for effectiveness of combined 
biomedical and psychological interventions (incorporating self-management approaches) on long 
term outcomes in the management of chronic orofacial (principally TMD) pain. Self-management 
should be a priority for early intervention in primary care in preference to invasive, irreversible and 
costly therapies. Further research is needed firstly to clarify the relative effectiveness of specific 
components of self-management, both individually and in conjunction, and secondly on outcomes in 




Psychosocial risk factors associated with chronic orofacial pain are amenable to self-management. 
However, current management involves invasive therapies which lack an evidence base and have 
the potential to cause iatrogenic harm.  
Objectives: 
To determine: 1) whether self-management is more effective than usual care in improving pain 
intensity and psychosocial well-being 2) optimal components of self-management interventions. 
Databases and Data treatment 
Cochrane Oral Health Group Trials Register, Cochrane Central Register of Controlled Trials, MEDLINE, 
EMBASE, PsycINFO, WHO International Clinical Trials Registry Platform and Clinical Trials.gov were 
searched. Meta-analysis was used to determine effectiveness and GRADE was used to rate quality, 
certainty and applicability of evidence.  
Results 
Fourteen trials were included. Meta-analyses showed self-management was effective for long-term 
pain intensity (standardised mean difference (SMD) -0.32, 95% confidence interval (CI) -0.47 to -
0.17) and depression (SMD -0.32, 95% CI -0.50 to -0.15). GRADE analysis showed a high score for 
certainty of evidence for these outcomes and significant effects for additional outcomes of activity 
interference (-0.29 95% CI -0.47 to - 0.11) and muscle palpation pain (SMD -0.58 95% CI -0.92 to -
0.24). 
Meta-regression showed non-significant effects for biofeedback on long-term pain (-0.16, 95% CI -
0.48 to 0.17, P-value = 0.360) and depression (-0.13, 95% CI -0.50 to 0.23, P-value = 0.475).  
Conclusions 
Self-management interventions are effective for patients with chronic orofacial pain. Packages of 
physical and psychosocial self-regulation and education appear beneficial. Early self-management of 
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BACKGROUND 
Persistent pain in the face or mouth is a frequent causes for consultation in both primary dental and 
medical care and in a substantial proportion of cases it can become both chronic and disabling 
(Aggarwal et al., 2008; Macfarlane et al., 2002). Subjects who report orofacial pain for three months 
or more report increased pain level and disability and are also more likely to seek treatment and 
take medication (Macfarlane et al., 2002). Chronic orofacial pain (OFP) is the characteristic feature of 
a number of clinical conditions such as temporomandibular joint disorder (TMD), burning mouth 
syndrome, atypical odontalgia and atypical facial pain that are difficult to diagnose and treat 
(Durham et al., 2007; Elrasheed et al., 2004; Pfaffenrath et al., 1993). TMD is globally the most 
common orofacial pain condition and in the United States a prevalence of 6% in women and 3.5% in 
men has been reported (Lipton et al., 1993); in the UK the prevalence of chronic orofacial pain is 
similar at 7% (Aggarwal et al., 2006). The American Academy of Orofacial pain suggests that in any 
given year 10% of women and 6% of men (approximately 20 million adults) have TMD pain (Gatchel 
et al., 2006). Reports from European studies also have similar prevalence figures (6.7%) for TMD 
(Johansson et al., 2003).  
Patients with chronic orofacial pain are likely to be frequent consulters to primary, secondary and 
tertiary care and undergo multiple investigations to determine an organic cause for their symptoms - 
although underlying organic pathology is rarely found (Durham et al., 2007; Elrasheed et al., 2004; 
Pfaffenrath et al., 1993). Management of chronic orofacial pain by dentists tends to focus on 
correction of local mechanical factors such as teeth grinding and malocclusion. However evidence in 
the form of Cochrane systematic reviews has shown little or no beneficial effects of invasive physical 
therapies such as irreversible occlusal adjustments (Koh and Robinson 2003) and oral splints (Al-Ani 
et al., 2005; List and Axelsson 2010). Indeed an audit of 101 consecutive referrals of persistent 
orofacial pain to a secondary care Oral Surgery department (Beecroft et al., 2013) showed that 
patients had been treated in nine different hospitals; referred to 15 distinct specialties with a mean 
of 7 consultations per specialty. Overall 341 treatment attempts had been made and only 24% 
yielded a successful outcome. The study concluded that there was a need for evidence based 
management and specialist regional centres (Beecroft et al., 2013). 
Patients with orofacial symptoms also frequently consult their general medical practitioner (69%) 
rather than general dental practitioners (31%) (Bell et al., 2008). General medical practitioners do 
not have the infrastructure or knowledge to manage chronic orofacial pain and indeed find it 
difficult (Peters et al., 2015). Patients are therefore referred from specialist to specialist and have 
multiple tests, investigations and often invasive and irreversible treatments that do not improve 
symptoms (Beecroft et al., 2013; Durham et al., 2007; Elrasheed et al., 2004; Pfaffenrath et al., 
1993). Costs of TMD alone in the United States are in the region of $4 billion annually (Gatchel et al., 
2006) and a study examining the costs to the UK National Health Service (Durham et al., 2016b) 
showed that consultation costs were a significant proportion (p<0.001) of cumulative healthcare 
utilization costs of patients with persistent orofacial pain. This imposes a huge burden on already 
stretched health care resources. The descriptive epidemiology of chronic orofacial shows a strong 
association with psychosocial risk factors (Aggarwal et al., 2008; Bair et al., 2016; Slade et al., 2007; 
Slade et al., 2016) and a co-occurrence with other long term conditions like chronic widespread pain 
(CWP), irritable bowel syndrome (IBS) and chronic fatigue (CF) (Aggarwal et al., 2006; Bair et al., 
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In line with a global drive to curb the epidemic of non-communicable diseases and long term 
conditions, UK government policy places an emphasis on using self-management to improve 
management of long term conditions through patient participation and ownership of their own 
healthcare (Department of Health 2001; 2005).  Self-management approaches (where the 
person takes an active role  in managing their condition rather than a passive one  that 
is  more dependent on  others) are  increasingly accepted for  chronic pain (Nicholas and 
Blyth 2016). This term refers to all actions taken by individuals to manage the symptoms, treatment, 
physical and psychosocial consequences and lifestyle changes inherent in living with a chronic 
condition (Barlow et al., 2002). Self-management interventions aim to increase the capacity, 
confidence and efficacy of the individual and are increasingly viewed as core strategies of the 
management of chronic conditions (Kennedy et al., 2013). Education and skill development are two 
common components of those interventions that are tailored to influence individual’s cognitive, 
behavioural and emotional responses to maintain and strengthen a satisfactory quality of life 
(Barlow 2001). The boundary between “active” and “passive” treatment however is not absolute and it 
could be argued that anything done by the patient in an endeavour to better manage their symptoms, 
function or associated distress could be viewed as self-management. However the term self-
management approach, normally has a specific cognitive or behavioural focus and is normally 
contrasted with passive treatment primarily delivered by a healthcare practitioner. Currently it is 
normally taken to apply to pain coping strategies employed by the patient to help manage their pain 
and its impact. This aligns with TMD interventions which aim to target these factors using techniques 
such as psychoeducation, relaxation, jaw posture control, cognitive behaviour therapy (CBT) and 
biofeedback as per previous studies (Goldthorpe et al., 2016a; Litt et al., 2009; Turner et al., 2007; 
Turner et al., 1995). These studies have not only outlined components for biopsychosocial 
interventions for chronic orofacial pain and TMD but also explored the mechanisms by which self-
care interventions involving both psychosocial self-care and jaw posture control can bring about 
change in patients with chronic orofacial pain. Guided self-care interventions can target vicious 
cycles associated with both fear-avoidance behaviour (central pain processing mechanisms) and 
'anxiety-pain-tension' cycles involving muscle over activity linked to emotional stress (depression, 
anger, fears and anxieties about the pain) which in turn may increase pain by precipitating activity in 
psychophysiological systems. By changing patient beliefs and developing coping strategies self-
management interventions have the potential to induce a return to normal functioning. (Goldthorpe 
et al., 2016a; Litt et al., 2009; Turner et al., 2007; Turner et al., 1995). Such interventions are non-
invasive and have the potential, if effective, to be applied across healthcare and delivered by general 
medical practitioners to whom patients with orofacial symptoms frequently consult.  
Key components of such interventions have included psychoeducation, relaxation, CBT and 
biofeedback (Goldthorpe et al., 2016a; Litt et al., 2009; Turner et al., 2007; Turner et al., 1995). 
However biofeedback, in particular EMG biofeedback (Gatchel et al., 2006), requires not only 
expensive equipment but also time spent on training and particularly time spent by patients on 
practice. This may not be amenable to self-management particularly for interventions that need to 
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The aim of the current review was therefore to assess the effectiveness of self-management 
interventions compared with usual care in the management of adults with chronic orofacial pain.  
 
Specific Objectives: 
1. To determine whether, in adults with chronic orofacial pain including temporomandibular 
disorders (TMD), self-management interventions more effective than usual care in improving 
long term outcomes related to pain intensity and psychosocial well-being.  
2. To determine whether the biofeedback component of interventions shows an additional 
treatment effect compared to no biofeedback. 
3. To determine the effectiveness of self-management for subtypes of chronic orofacial pain in 




This systematic review and meta-analysis was undertaken following the Preferred Reporting Items 
for Systematic reviews and Meta-Analyses (PRISMA) statement (Liberati et al., 2009; Moher et al., 
2009). This study is registered with PROSPERO (CRD42017060158 (Aggarwal et al., 2018)). 
 
Criteria for considering studies for this review 
Types of studies  
Randomised controlled trials which included self-management of chronic orofacial pain compared 
with any other form of treatment such as surgery, usual care, pharmacological treatment and/or 
waiting list controls. 
 
Types of participants 
Adults over 18 years of age with chronic orofacial pain defined as those diagnosed with the following 
conditions: temporomandibular disorders (TMD), atypical facial pain, atypical odontalgia and 
burning mouth syndrome. Other terms used to describe these conditions were also included in the 
search strategy e.g. myofacial pain, myofascial pain related to the facial region, 
craniomandibular/oromandibular dysfunction, mandibular stress syndrome, facial arthromyalgia, 
masticatory muscle disorder, masticatory myalgia, TMJ syndrome, stomatodynia, persistent 
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Types of outcome measures 
Primary outcomes 
1. Pain intensity (short and/or long term) measured using a visual analogue scale or a validated 
categorical scale e.g. Brief Pain Inventory, Multidimensional Pain Inventory. 
2. Depression / Anxiety (long and short term using validated scales for example Hospital 
Anxiety and Depression Scale.  
3. Interference with life – pain impact on activities of daily living measured using e.g. Brief Pain 
Inventory, Multidimensional Pain Inventory. 
 
Types of interventions 
Self-management interventions were defined as those that included patient participation in the 
intervention. Table 1 illustrates the components of the interventions. Trials were eligible for 
inclusion into self-management as they included patient participation through a patient manual and/ 
or between session work as part of the intervention protocol. Other components were education, 
psychological such as Cognitive Behaviour Therapy or its components (Cognitive therapy, 
behavioural therapy) and physical self-regulation for example posture control, habit reversal, 
relaxation and/or biofeedback.  Table 1 summarises the intervention components of studies and 
how these map onto self-management.  
 
Search methods for identification of studies 
For the identification of studies included or considered for this review, detailed search strategies 
were developed for each database searched. These were based on the search strategy developed for 
MEDLINE (OVID) but revised appropriately for each database.  
 
The search attempted to identify all relevant studies irrespective of language. Electronic searches 
The following electronic databases were searched (to 29 September 2017): The Cochrane Oral 
Health Group Trials Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE 
via OVID, EMBASE via OVID, PsycINFO via OVID, WHO International Clinical Trials Registry Platform 
and Clinical Trials.gov. There were no restrictions regarding language or date of publication. The 
search strategy used a combination of controlled vocabulary and free text terms for identifying 
randomised trials (RCTs) in MEDLINE. Details of the search strategy are provided in Appendix 1.  
 
Searching other resources 
The reference lists of all eligible trials were checked for additional studies. Where these had not 
already been searched the journals were hand searched by the review authors if electronic copies 
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Data collection and analysis 
Selection of studies 
The title and abstracts of relevant articles and reports from the search strategy outlined in Appendix 1 
were screened independently by two review authors (VA and JW). Full reports were obtained where 
trials met the inclusion criteria or where a clear decision could not be made from the title or abstract. 
Disagreements were resolved by discussion and full reports of all studies potentially meeting the 
inclusion criteria were obtained. Full reports were used to assess trials where inclusion was unclear 
and reasons for rejection were clear upon examining full reports. Main reasons for rejection were: 
studies were not randomised controlled trials, had the wrong disease definition and / or patient group. 
  
Data extraction and management 
Data was extracted, independently and in duplicate, using a previously prepared data extraction 
form which included the characteristics of trial participants, interventions, control groups and 
outcomes. Characteristics of included studies are presented in appendix 2. VA extracted all the 
studies while JW and YF shared equally extraction for the purpose of duplication. Any differences 
were resolved by discussion. Differences involving risk of bias were resolved by using the most 
frequent option selected e.g. if two of the three reviewers were in agreement then we chose that 
option. There were no instances where there was disagreement between all 3 reviewers. Prior to 
extraction the data extraction form was piloted using three studies and all authors extracting the 
data participated in the piloting so that they were clear about the extraction process. The data 
extraction form was modified for ease of use following the pilot extractions. 
 
Assessment of risk of bias in included studies 
The assessment of risk of bias in the included trials was undertaken independently and in duplicate 
as part of the data extraction process by three of the review authors (VA, JW and YF) as described 
above and in accordance with the Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 
(Higgins and Green 2011). Included trials were assessed on the following criteria: 
 adequate sequence generation 
 concealed allocation of treatment 
 blinding of participants/caregivers (where feasible) and outcome assessors 
 incomplete outcome data 
 selective outcome reporting 
 any other bias relevant to the study 
A description of the quality items was tabulated for each included trial, along with a judgement of 
low, high or uncertain risk of bias. Criteria for risk of bias judgements regarding allocation 
concealment were as described in the Cochrane Handbook for Systematic Reviews of Interventions 
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 Low risk of bias - adequate concealment of the allocation (e.g. sequentially numbered, 
sealed, opaque envelopes or centralised or pharmacy-controlled randomisation). 
 Uncertain risk of bias - uncertainty about whether the allocation was adequately concealed 
(e.g. where the method of concealment is not described or not described in sufficient detail 
to allow a definite judgement). 
 High risk of bias - inadequate allocation concealment (e.g. open random number lists or 
quasi-randomisation such as alternate days, date of birth, or case record number). 
A summary assessment of the risk of bias for the primary outcome (across domains) within and 
across studies was undertaken. Within a study, a summary assessment of low risk of bias was given 
when there was a low risk of bias for all key domains, unclear risk of bias when there was an unclear 
risk of bias for one or more key domains, and high risk of bias when there was a high risk of bias for 
one or more key domains. Across studies, a summary assessment was rated as low risk of bias when 
most information is from studies at low risk of bias, unclear risk of bias when most information was 
from studies at low or unclear risk of bias, and high risk of bias when the proportion of information 
was from studies at high risk of bias sufficient to affect the interpretation of the results. 
 
Measures of treatment effect 
For dichotomous outcomes, treatment effects were expressed as risk ratios with 95% confidence 
intervals whilst for continuous outcomes mean differences with 95% confidence intervals were used. 
All analyses were performed using R version 3.4.1 (https://cran.r-project.org/)(R Core Team 2013). 
 
Assessment of heterogeneity 
Clinical heterogeneity was accounted for by inclusion criteria for uniform disease definition, 
assessing components of the interventions and outcome measures included in the trials. Statistical 
heterogeneity was assessed by means of Cochrane Q, where a large Q value indicates the presence 
of heterogeneity, and the I2 statistic where I2 gives the percentage of variability in the effect 
estimate that is due to heterogeneity rather than to chance. Suggested thresholds for the 
interpretation of I2 are as follows: less than 40% indicate there is no problem with heterogeneity, 
30–60% indicates a moderate problem, 60–90% a substantial problem and 75% and over 
considerable heterogeneity (Higgins and Green 2011). 
 
Assessment of reporting biases 
Reporting biases were assessed through funnel plots for outcomes that were reported by more than 
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Data synthesis 
Meta-analyses were only carried out if trials were of similar comparisons reporting the same 
outcome measures. Estimates of effect were combined using a random-effects model. Mean 
differences or standardised mean differences were used for the same outcomes with different 
scales. 
 
Quality of evidence 
We used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) 
approach to assess the quality and certainty of the body of evidence per outcome, in accordance 
with the Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 (Higgins and Green 
2011). For the most important outcomes, we used the programme GRADE pro GDT 2015 to generate 
a certainty of evidence table (Table 2). Starting from an assumed level of high quality, this reduced 
the quality of the evidence by one or more levels if there were one or more limitations in the risk of 
bias, consistency, and/or precision of the pooled estimate. The level of evidence as then rated as 
either high, moderate, low or very low depending on the number of limitations. 
 
Assessment of intervention components: 
Meta-regression 
Simple mixed-effects meta-regression was used to investigate whether biofeedback provided 
additional treatment effect. We performed meta-regression on outcome measures of long-term pain 
and depression between patients with biofeedback and those without biofeedback. 
 
RESULTS 
Description of studies 
A detailed description of the studies is in the characteristics of included and excluded studies 
presented in appendix 2. 
 
Results of the search 
The initial search strategy yielded 1104 references which were assessed blind and independently by 
VA and JW, and based on the abstracts and titles these were reduced to 48 relevant manuscripts 
(Figure 1). Main reasons for exclusion were that a large proportion of studies were not trials and 
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All the 48 manuscripts identified above were extracted by the lead author VA. Extraction was 
duplicated by sharing blind and independently between the other co-authors (JW, YF). Sixteen 
manuscripts were relevant for analysis and are presented in the characteristics of included studies 
table in appendix 1. A number of trials that were duplicates of the same study were merged. 
Reasons for exclusion at this stage were interventions not compatible with self-management, had 
the wrong disease definition and/or patient group and they were not randomised controlled trials. 
Of the 16 studies which met all eligibility criteria and hence included in this review, Dworkin's 2 
studies (Dworkin et al., 2002a; Dworkin et al., 2002b) and Komiyama's study (Komiyama et al., 1999) 
displayed results graphically and we did not have means and standard deviations to pool these 
studies. Authors were contacted to obtain data but only provided means and no standard deviations 
or did not respond. This left 14 studies for inclusion in the final meta-analysis (Figure 1). 
 
Included studies 
All of the included trials had comparable control groups comprising usual treatment which involved 
conservative treatment composed of education, counselling and an intra-oral flat plane appliance. 
The Bergdahl study (Bergdahl et al., 1995) included a control group of attention placebo and the 
Townsend study (Townsend et al., 2001) including a waiting list control with no intervention and 
were therefore not pooled in the meta-analysis as they had a different comparators. They were 
however used for the GRADE analysis (table 2). 
The interventions for self-management were as defined previously. Outcome measures included 
short-term (3 months or less) and long term (more than 3 months) pain intensity and long term 
measures for muscle palpation pain, activity interference and depression. 
 
Risk of bias in included studies 
Risk of bias plots are displayed in Figure 2a and 2b; the former showing the overall risk of bias and 
the latter individual plots for each study. Figure 2c shows funnel plots for publication bias.  
 
Blinding (performance bias and detection bias) 
It is notable that due to the nature of the intervention, blinding was difficult where the intervention 
and controls were concerned. However it was possible for outcome assessment and for the 
purposes of this review we evaluated whether included studies had blinded outcome measurement. 
This was reported by seven of the included studies (Carlson et al., 2001; Dworkin et al., 1994; 
Ferrando et al., 2012; Gardea et al., 2001; Goldthorpe et al., 2017; Shedden-Mora et al., 2013; 
Turner et al., 2006) and three did not report at all (Bergdahl et al., 1995; Gatchel et al., 2006; Litt et 
al., 2010). The remaining studies were unclear (Figure 2b).  The overall risk of bias was deemed low 
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Incomplete outcome data (attrition bias) 
Only three trials did not report on incomplete outcome data; nine fully reported this (Bergdahl et al., 
1995; Carlson et al., 2001; Dworkin et al., 1994; Ferrando et al., 2012; Gardea et al., 2001; Gatchel et 
al., 2006; Goldthorpe et al., 2017; Shedden-Mora et al., 2013; Turner et al., 2006) and the one was 
unclear (Litt et al., 2010) and risk of bias (Figure 2b) was therefore low for this domain (Figure 2a). 
 
Allocation (selection bias) 
This was not reported by only three of the included studies (Ferrando et al., 2012; Litt et al., 2010); 
fully reported by four studies (Gardea et al., 2001; Goldthorpe et al., 2017; Shedden-Mora et al., 
2013; Turner et al., 2006) and the remaining studies were unclear (Figure 2b). Overall the risk of bias 
in this area was therefore low (Figure 2a). 
 
Selective reporting (reporting bias) 
None of the included trials had selective reporting and therefore were assessed as being at low risk 
of bias for selective reporting (Figure 2a). 
 
Publication Bias 
There were only two outliers for short term pain intensity and one for long term pain intensity and 
activity interference for funnel plots (Figure 2c) which may indicate the existence of publication bias. 
However, formal tests showed that this was not statistically significant (Egger’s test, P-value for 
short term pain = 0.35, long term pain = 0.52, activity interference = 0.34 and Long –term depression 
= 0.69). 
 
Effectiveness of self- management interventions 
Self- management interventions versus usual care Pain (short term) 
Nine studies provided comparable data for this outcome (Carlson et al., 2001; Crockett et 
al., 1986; Dworkin et al., 1994; Ferrando et al., 2012; Gardea et al., 2001; Goldthorpe et al., 
2017; Litt et al., 2010; Shedden-Mora et al., 2013; Turk et al., 1993). 
Due to substantial heterogeneity (I2 = 62%), the results of these studies could not be pooled (Figure 
3). Hence no overall conclusions could be drawn for this domain. Of the studies that did not have 
quantitative data for this outcome, the Komiyama paper (Komiyama et al., 1999) showed no 
differences in pain intensity between the self-management intervention and control groups. In 
contrast the Dworkin comprehensive care programme study (Dworkin et al., 2002a) showed 
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Self-management interventions versus usual care - Pain (long term) 
Nine studies provided data on this outcome (Carlson et al., 2001; Dworkin et al., 1994; 
Gardea et al., 2001; Gatchel et al., 2006; Goldthorpe et al., 2017; Litt et al., 2010; Shedden-
Mora et al., 2013; Turk et al., 1993; Turner et al., 2006). 
Due to low heterogeneity (I2 = 7%) the results of the studies could be pooled for the 
purpose of statistical analysis (Figure 4). This showed a statistically significant difference in 
favour of self-management interventions (SMD -0.32, 95% CI -0.47 to -0.17), and this 
represented a 16% improvement in long-term pain for self-care versus usual care for 
patients with chronic orofacial pain (Figure 4). 
Considering subgroups of interventions, statistically significant differences were observed 
for self-care CBT (SMD -0.26, 95% CI -0.45 to -0.07) and combined biofeedback and CBT 
(SMD -0.46 95% CI −0.72 to −0.20) (Figure 4). Of the studies that did not have quantitative 
data for this outcome the Dworkin self-care intervention (Dworkin et al., 2002a) showed 
significant (p<0.05) improvement in long term pain intensity whist the comprehensive care 
programme study (Dworkin et al., 2002b) did not. 
 
Self-management interventions versus usual care - Muscle palpation pain (long term) 
Overall only three studies provided data on this outcome (Carlson et al., 2001; Turk et al., 
1996; Turk et al., 1993). 
Only three studies provided data on this outcome and because there was substantial heterogeneity 
(I=63%) the pooled results were unreliable although they showed a significant improvement in 
muscle palpation pain (SMD -0.58 95% CI −0.92 to −0.24) (Table 3). There was insufficient data to 
draw any conclusions regarding any of the individual interventions with regard to muscle palpation 
pain (long term). Of the studies that did not have quantitative data for this outcome the Dworkin 
self-care intervention (Dworkin et al., 2002a) showed significant (p<0.05) improvement in this 
outcome. 
 
Self-management interventions versus usual care - Activity interference (long term) 
A total of eight studies provided data for this outcome (Carlson et al., 2001; Dworkin et al., 
1994; Ferrando et al., 2012; Gardea et al., 2001; Goldthorpe et al., 2017; Litt et al., 2010; 
Shedden-Mora et al., 2013; Turk et al., 1996). 
Eight studies provided data for this outcome and there was a significant effect of the pooled results 
(SMD -0.29 95% CI -0.47, -0.11) (Table 3). However because there was substantial heterogeneity 
(I2=79%) the pooled results are unreliable. Individually, there were statistically significant difference 
for self-care CBT (SMD -0.37 95% CI -0.57, -0.16). Of the studies that did not have quantitative data 
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(p<0.05) improvement in this outcome whilst the comprehensive care programme study (Dworkin et 
al., 2002b) did not. 
 
Self-management interventions versus usual care - Depression (long term) 
A total of seven studies provided data for the statistical analysis for this outcome (Carlson 
et al., 2001; Gatchel et al., 2006; Goldthorpe et al., 2017; Litt et al., 2010; Shedden-Mora et 
al., 2013; Turk et al., 1996; Turk et al., 1993). 
Overall seven studies provided data on this outcome and there were statistically significant 
differences in favour of psychosocial interventions (SMD -0.32, 95% CI -0.50 to -0.15) (Figure 5) and 
this represented a 25% improvement in long term pain for psychosocial interventions versus usual 
care. There was no heterogeneity (I2=0%) (Figure 5). 
Individually, both self-care CBT and CBT/biofeedback show statistically significant benefit over usual 
care with regard to depression (SMD -0.27, 95% CI -0.49 to -0.05) and (SMD -0.41, 95% CI -0.68 to -
0.13) respectively (Figure 5). 
 
Certainty of the evidence 
The certainty of the evidence was high for the main outcome measures as assessed using GRADE 
criteria (Table 2). For the key outcome measures of long term pain intensity and depression there 
were 757 participants (12 RCTs) and 524 participants (8 RCTs) respectively.  
For other outcome measures that were not pooled, the quality of evidence was also high and 
significant effects were observed for the effects of self-management interventions on activity 
interference (SMD -0.29, 95% CI -0.47 to -0.11) and long term muscle palpation pain (SMD -0.58, 
95% CI -0.92 to -0.24). The effect for short term pain remained non-significant (SMD -0.06, 95% CI -
0.21 to 0.09). 
 
Subgroup analysis 
A subgroup analysis for trials that only included TMD studies showed similar significant effects on 
long term pain and depression SMD -0.34 (-0.50, -0.19) and -0.33 (-0.51, -0.15) and results could be 
pooled due to low heterogeneity (Table 4).  
 
Components of self-management 
Meta regression was conducted to test whether biofeedback component showed an additional 
treatment effect compared with no biofeedback. The outcomes of long-term pain and depression 
were used to assess this effect. Of the 11 studies reporting long-term pain, 5 studies also used 
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biofeedback was (-0.16, 95% CI -0.48 to 0.17, P-value = 0.360). Of the 8 studies reporting long-term 
depression, 3 studies also used biofeedback in the intervention. The coefficient estimate from meta-
regression for using biofeedback was (-0.13, 95% CI -0.50 to 0.23, P-value = 0.475).  
 
DISCUSSION 
Summary of main results 
This systematic review has shown for the first time that there is strong evidence to support the use 
of self-management interventions to improve long-term outcomes for patients with chronic 
orofacial pain and TMD. There were significant effects for improvement in long-term pain and 
depression, the studies were at low risk of bias and there were sufficient numbers of studies that 
could be pooled to give an overall treatment effect. The quality and certainty of evidence for the 
main outcome measures (pain and depression) was high using GRADE scores. For other outcome 
measures the quality of evidence was also high in GRADE despite the heterogeneity observed for 
these outcomes in the meta-analysis. Self-management interventions therefore also showed 
significant improvement on activity interference and long term muscle palpation pain. 
The descriptive analysis of studies and interventions used showed that all but two of the included 
studies were on TMD and that self-management interventions for chronic orofacial pain (mainly 
TMD) include education, physical (jaw posture relaxation) and psychosocial (cognitive, behavioural) 
self-regulation. Meta-regression showed that biofeedback did not provide additional contribution to 
effect size.  Given that some types of biofeedback, such as masseter EMG biofeedback, require 
additional expensive equipment, training and particularly time for patients to practise, further 
evaluation is required on the value of biofeedback in self-management of chronic orofacial pain.  
 
Implications for management of chronic orofacial pain 
Overall, the components identified by the review map onto a biopsychosocial intervention model 
involving both physical and psychological approaches to the management of chronic orofacial pain 
(mainly TMD). This is not dissimilar to approaches identified for management of chronic back pain 
(with which TMD co-occurs) and which have been shown to be cost-effective (Hill et al., 2013; Hill et 
al., 2011; Main et al., 2012). 
Physical self-regulation and education as active components for TMD self-management are 
supported by a Delphi study. It showed that main components of a standard self-care programme of 
TMD were agreed to comprise education; self-exercise; self-massage; thermal therapy; dietary 
advice and nutrition; and parafunctional behaviour (Durham et al., 2016a). However it did not 
include psychological components which were shown to be integral in the management of TMD in 
our current systematic review. Previous studies using a predominantly psychosocial approach 
(Goldthorpe et al., 2017) identified the need for physical self-regulation as an additional component. 
It was not included in their patient manual, but recognised as an important component for 
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Indeed current recommendations for TMD management (The European Pain Federation) state that 
physiotherapy and pain management psychology can be useful. This is in agreement with the 
descriptive components of self-management interventions identified in our review that show 
packages of both physical and psychosocial components appear beneficial. Future research needs to 
explore how these approaches interact separately and / or combined in a single intervention. Indeed 
this can have implications for pain management programmes including those for orofacial pain 
which tend to address physical and psychosocial management separately e.g. by referral to a 
physiotherapist and /or clinical psychologist. It may be that such interventions delivered as a 
package by skilled clinicians using a biopsychosocial approach may be more appropriate. Indeed it 
has been found to be effective for physiotherapists to deliver a self-management package 
(comprising education, physical and psychosocial components) for biopsychosocial management of 
back pain (Hill et al., 2013; Hill et al., 2011; Main et al., 2012).  Both future trials and current pain 
management programmes for chronic orofacial pain and TMD should prioritise a biopsychosocial 
approach that includes education, physical and psychosocial components. Indeed self-reports of jaw 
parafunction, psychosocial factors and reporting of other somatic symptoms have been shown to be 
the strongest predictors of TMD the large prospective OPERRA study (Slade et al., 2007; Slade et al., 
2016). These risk factors lend themselves to the biopsychosocial approach identified by the findings 
of the current systematic review. 
It is important to note that the trials included in the current review were mainly on TMD. The 
physical self-regulation (jaw posture relaxation) component is therefore relevant to TMD alone 
rather than all facial pain subtypes as TMD is commonly associated with parafunctional habits 
(Durham et al., 2016a). Future research needs to explore the effects of self-management on all facial 
pain subtypes as per the study by Goldthorpe et al., (2017) and determine whether physical self-
regulation components are effective for other subtypes of chronic orofacial pain.  
Implications for future research  
The studies eligible for inclusion in this review were conducted in secondary care where patients had 
developed long-standing chronic orofacial pain.  Given the effectiveness of self-management in this 
group of patients, future studies need to be conducted in primary care to explore whether early 
intervention can improve outcome by preventing chronicity. This certainly appears to be the case for 
early intervention in tertiary care (Gatchel et al., 2006). Future trials also need to standardise 
outcome measures so that they can be comparable across trials.  In the current review, we were 
able to compare effectiveness for pain intensity and physical and emotional functioning using 
outcomes available in the included trials. Of these, only outcomes for pain intensity and emotional 
functioning (depression was the only outcome across trials that was measured) could be pooled in 
the meta-analysis. Physical functioning represented by activity interference could not be pooled due 
to high heterogeneity. Outcome measures for these domains (pain intensity, physical and emotional 
functioning) need to be standardized for future trials so that results can be compared across trials 
and pooled for meta-analyses. Core outcome measures for chronic pain in clinical trials have been 
clearly defined by initiatives such as IMMPACT and these would appear to be an appropriate 
benchmark (Turk et al., 2008) for future trials on chronic orofacial pain and TMD. Indeed there are 
several dimensions of emotional functioning like fear of pain, catastrophizing and anxiety that are 
relevant to pain management but due to the lack of homogeneity in their measurement we were 
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Future work that explores the mechanisms by which these interventions bring about change is also 
needed to inform outcome measures. For example, Turner et al  (Turner et al., 2007) examined 
potential mediators, moderators and predictors of patient improvement with CBT. It was a novel 
study that examined whether pre to post treatment process variable changes mediated CBT effects 
on subsequent outcomes (Turner et al., 2007). The results showed that change in perceived pain 
control and self-efficacy were important in explaining the treatment effects of CBT on the outcomes 
and should be considered in designing future behavioural interventions for TMD. A further study by 
Litt (Litt et al., 2010) also showed that somatization, self-efficacy and readiness for treatment were 
significant moderators. Work by our group assessed processes of engagement with a self-
management intervention and this showed that key mechanisms of change centred around: 
identification with the intervention; feeling believed and understood; obtaining a plausible 
explanation for symptoms; degree of perceived effort required to engage; acceptance of having a 
long-term condition; and receiving demonstrative, positive feedback (Goldthorpe et al., 2016b). 
These studies indicate that self-efficacy, pain control, and understanding and accepting the 
chronicity of the conditions are important biopsychosocial predictors of patient improvement and 
should be incorporated into future interventions. This is similar to other chronic pain conditions like 
chronic back pain whereby mediators like obtaining a plausible explanation for symptoms and 
knowledge of the condition have led to the development of public health approaches (Roland et al., 
2002; Waddell and Moffett 2004; Williams et al., 2009). Such approaches need to be considered for 
chronic orofacial pain and TMD and indeed specific self-management advice can be included in both 
primary care dental and medical practices. Over the counter pain relief (non-steroidal anti-
inflammatory drugs) are particularly useful for TMD pain and can be incorporated into self-
management plans. This will avoid the need for costly invasive and irreversible procedures like 
surgery, occlusal rehabilitation and splints. 
Quality of the evidence in the review and comparison to previous reviews 
The risk of bias pertaining to each item discussed in the results section was low for the majority of 
domains used in the assessment. The GRADE scoring showed that the certainty of evidence was high 
for all the outcome measures. Therefore the quality of the evidence was high for trials included in 
the review. The component analysis showed that all trials included self-management and physical 
and psychosocial self-regulation. Only six studies included biofeedback for which we were able to 
conduct a meta-regression. This showed that biofeedback alone does not produce an effect in the 
meta-regression model with very low residual heterogeneity (I2 = 7%). 
The results of the current review update the findings of our previous Cochrane systematic review 
(Aggarwal et al., 2011) which showed that psychosocial interventions were effective in improving 
long term outcomes for patients with chronic orofacial pain. However that review failed to 
acknowledge the importance of the components within the interventions and grouped all 
interventions into a psychosocial group. In addition the evidence was weak as few studies were 
included and an overall quality assessment of the quality of evidence was not conducted. Other 
systematic reviews in this area (Liu et al., 2012; Randhawa et al., 2016) have suffered from 
methodological shortcomings due to the limited amount of studies, lack of meta-analysis and 
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Potential biases  
Given that the majority of interventions were delivered by a therapist, bias arising from therapeutic 
alliance related to the quality of doctor-patient relationship may be present which can drive non-
specific effects (placebo Effect in clinical practice, and Hawthorne effect in clinical studies). Further, 
included studies were conducted in tertiary care settings which specialised in the management of 
chronic orofacial pain. This may affect the generalizability of the results as patients in these settings 
are likely to represent the more severe and intractable cases of chronic orofacial pain and hence 
share common characteristics. Future trials need to explore early management of chronic orofacial 
pain in primary care using these interventions. Whist we concluded that overall risk of bias was low 
and indeed trials by Turner et al., (2006) and Shedden-Mora et al., (2013) were completely free of 
the domains of bias assessed, data permitting, we would have used sensitivity analyses to examine 
the effect of concealed allocation, intention-to-treat analysis and blind outcome assessment on the 
overall estimates of effect. 
 
CONCLUSIONS  
The findings of this review provide strong evidence for the use of non-invasive self-management 
interventions for patients with chronic orofacial pain (mainly TMD). The components of these 
interventions included physical self-regulation (jaw posture regulation), psychosocial (cognitive and 
behavioural) self-regulation and education. Future work needs to prioritise the use of these 
interventions in early management of chronic orofacial pain including TMD. 
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TABLE LEGENDS 
Table 1 Components of self-management interventions for included studies 
Table 2 GRADE analysis showing certainty of evidence for self-management compared to usual care 
for chronic orofacial pain 
Table 3 Effectiveness of self-management compared to usual care for muscle palpation pain and 
activity interference 




Figure 1 PRISMA flow diagram 
Figure 2a Overall risk of bias 
Figure 2b Risk of bias for individual studies. Green circles with ‘+’ symbol indicate low risk of bias; 
yellow circles with ‘?’ symbol indicate unclear risk of bias; red circles with ‘–‘ symbol indicate high 
risk of bias. 
Figure 2c Funnel plots for outcomes reported by more than 5 studies. Dots outside the funnel 
indicate outliers (Egger’s test p-values: short term pain = 0.35; long term pain = 0.52; activity 
interference = 0.34; Long –term depression = 0.69) 
Figure 3 Comparison - Any self-management intervention versus usual care Outcome - Pain short 
term (3months or less) 
Figure 4 Comparison – Self- management intervention versus usual care Outcome - Pain long term 
(greater than 3 months) 
Figure 5 Comparison - Any self-management intervention versus usual care Outcome - Depression 
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Table 2: Certainty of evidence for self-management compared to usual care for chronic orofacial pain 
 








Anticipated absolute effects 
Risk with 
Usual care 
Risk difference with 
Self-management 
Pain short term (<= 3 months)  
assessed with: VA, YF, JW  
779 
(14 RCTs)  
⨁⨁⨁⨁ 
HIGH  
-  SMD 0.06 SD lower 
(0.22 lower to 0.09 
higher)  
Pain long term (>3 months)  
assessed with: VA, YF, JW  
757 
(12 RCTs)  
⨁⨁⨁⨁ 
HIGH  
-  SMD 0.32 SD lower 
(0.47 lower to 0.17 
lower)  
Muscle palpation pain long 
term  
(> 3 months) 
assessed with: VA, YF, JW  
143 
(3 RCTs)  
⨁⨁⨁⨁ 
HIGH  
-  SMD 0.58 SD lower 
(0.92 lower to 0.24 
lower)  
Activity interference / 
disability  
(> 3 months)  
assessed with: VA, YF, JW  
527 
(10 RCTs)  
⨁⨁⨁⨁ 
HIGH  
-  SMD 0.29 SD lower 
(0.47 lower to 0.11 
lower)  
Depression long term (> 3 
months)  
assessed with: VA, YF, JW  
524 
(8 RCTs)  
⨁⨁⨁⨁ 
HIGH  
-  SMD 0.32 SD lower 
(0.5 lower to 0.15 
lower)  
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk 
in the comparison group and the relative effect of the intervention (and its 95% CI).  
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Table 4: Subgroup analysis of effectiveness of self-management for TMD alone 
 
Outcomes Intervention Control 
No. of 
studies 
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Appendix 1. SEARCH STRATEGY 
 
MEDLINE (OVID) search strategy 
1. CRANIOMANDIBULAR DISORDERS/ 
2. (“temporomandibular$” or “temporo-mandibular”).mp. 
3. tmj.mp. ortmd.ti,ab. 
4. exp MYOFASCIAL PAIN SYNDROMES/ 
5. (myofascial and (pain$ or disorder$ or dysfunction$)).mp. 
6. (myofacial and (pain$ or disorder$ or dysfunction$)).mp. 
7. (atypical and odontol$).mp. 
8. (atypical and toothache$).mp. 
9. (atypical and “tooth pain”).mp. 
10. “phantom tooth pain”.mp. 
11. exp Facial Pain/ 
12. (atypical and “facial pain”).mp. 
13. (atypical and “facial neuralgia”).mp. 
14. or/1-14 
15. exp BEHAVIOR THERAPY/ 
16. PSYCHOTHERAPY/ 
17. AUTOGENIC TRAINING/ 
18. exp COUNSELING/ 
19. SOCIAL SUPPORT/ 
20. (“behaviour therap$” or “behaviortherap$”).mp. 
21. counsel$.mp. 
22. “autogenic train$”.mp. 
23. (psychotherap$ or psychoanal$).mp. 
24. (“self-help group” or “self help group” or communicat$ or educat$ or inform$).mp. 
25. or/20-25 
36. 15 and 25 
The above subject search was linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) 
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MEDLINE: sensitivity maximising version (2009 revision) as referenced in Chapter 6.4.11.1 and 
detailed in box 6.4.c of The Cochrane 
Handbook for Systematic Reviews of Interventions, Version 5.0.2 [updated September 2009] 
(Higgins 2011): 
1. randomized controlled trial.pt. 








10. exp animals/ not humans.sh. 
11. 9 not 10 
 
The Cochrane Oral Health Group Register Search Strategy 
((“temporomandibular” or “temporo-mandibular” or “myofascial pain*” or “myofacial pain*” or 
“myofascial disorder*” or “myofacial disorder*” or “myofascial disorder*” or “myofacial 
disorder*” or toothache or “tooth pain*” or “facial pain*” or “facial neuralgia*” or “persistent 
idiopathic facial pain*”) AND (“behaviour therap*” or “behaviortherap*” or counsel* or 
“autogenic train*” or psychotherap* or psychoanal* or self-help or “self help” or communicat* or 
inform* or educat*)) 
 
 
Cochrane Central Register of Controlled Clinical Trials (CENTRAL) Search Strategy 
#1 MeSH descriptor Craniomandibular Disorders this term only 
#2 (temporomandibular* in All Text or temporo-mandibular* in All Text) 
#3 (tmj in Title, Abstract or Keywords or tmd in Title, Abstract or Keywords) 
#4 MeSH descriptor MYOFASCIAL PAIN SYNDROMES this term only 
#5 (myofascial in All Text and (pain* in All Text or disorder* in All Text or dysfunction* in All 
Text)) 
#6 (myofacial in All Text and (pain* in All Text or disorder* in All Text or dysfunction* in All 
Text)) 
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#8 (atypical in All Text and toothache* in All Text) 
#9 (atypical in All Text and “tooth pain” in All Text) 
#10 “phantom tooth pain” in All Text 
#11 MeSH descriptor Facial Pain explode all trees 
#12 (atypical in All Text and “facial pain” in All Text) 
#13 (atypical in All Text and “facial neuralgia” in All Text) 
#14 (#1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14) 
#15 MeSH descriptor BEHAVIOR THERAPY explode all trees 
#16 MeSH descriptor Psychotherapy this term only 
#17 MeSH descriptor AUTOGENIC TRAINING this term only 
#18 MeSH descriptor Counseling explode all trees 
#19 MeSH descriptor Social Support this term only 
#20 (“behaviour therap*” in All Text or “behaviortherap*” in All Text) 
#21 counsel* in All Text 
#22 “autogenic train*” in All Text 
#23 (psychotherap* in All Text or psychoanal* in All Text) 
#24 (“self-help group” in All Text or “self help group” in All Text or communicat* in All Text or 
educat* in All Text or inform* in 
All Text) 
#25 (#15 or #16 or #17 or #18 or #19 or #20 or #21 or #22 or #23 or #24) 
#25 (#14 and #25) 
 
 
EMBASE (OVID) Search Strategy 
1. exp CRANIOMANDIBULAR DISORDERS/ 
2. (“temporomandibular$” or “temporo-mandibular”).mp. [mp=title, original title, abstract, 
name of substance word, subject 
heading word] 
3. tmj.mp. ortmd.ti,ab. [mp=title, original title, abstract, name of substance word, subject 
heading word] 
4. exp MYOFASCIAL PAIN SYNDROMES/ 
5. (myofascial and (pain$ or disorder$ or dysfunction$)).mp. [mp=title, original title, abstract, 
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heading word] 
6. (myofacial and (pain$ or disorder$ or dysfunction$)).mp. [mp=title, original title, abstract, 
name of substance word, subject 
heading word] 
7. (atypical and odontol$).mp. 
8. (atypical and toothache$).mp. 
9. (atypical and “tooth pain”).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word] 
10. “phantom tooth pain”.mp. 
11. exp Facial Pain/ 
12. (atypical and “facial pain”).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word] 
13. (atypical and “facial neuralgia”).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word] 
14. or/1-13 
15. exp BEHAVIOR THERAPY/ 
16. PSYCHOTHERAPY/ 
17. AUTOGENIC TRAINING/ 
18. exp COUNSELING/ 
19. SOCIAL SUPPORT/ 
20. (“behaviour therap$” or “behaviortherap$”).mp. [mp=title, original title, abstract, name of 
substance word, subject heading 
word] 
21. counsel$.mp. 
22. “autogenic train$”.mp. 
23. (psychotherap$ or psychoanal$).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word] 
24. (“self-help group” or “self help group” or communicat$ or educat$ or inform$).mp. [mp=title, 
original title, abstract, name of 
substance word, subject heading word] 
25. or/15-24 
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3. (crossover$ or cross over$ or cross-over$).ti,ab. 
4. placebo$.ti,ab. 
5. (doubl$ adj blind$).ti,ab. 




10. CROSSOVER PROCEDURE.sh. 
11. DOUBLE-BLIND PROCEDURE.sh. 
12. RANDOMIZED CONTROLLED TRIAL.sh. 
13. SINGLE BLIND PROCEDURE.sh. 
14. or/1-13 
15. ANIMAL/ or NONHUMAN/ or ANIMAL EXPERIMENT/ 
16. HUMAN/ 
17. 16 and 15 
18. 15 not 17 
19. 14 not 18 
 
 
PsycINFO (OVID) Search Strategy 
 
1. exp Myofascial pain/ 
2. (“temporomandibular$” or “temporo-mandibular”).mp. [mp=title, abstract, heading word, 
table of contents, key concepts] 
3. tmj.mp. ortmd.ti,ab. [mp=title, abstract, heading word, table of contents, key concepts] 
4. (myofascial and (pain$ or disorder$ or dysfunction$)).mp. [mp=title, abstract, heading word, 
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5. (myofacial and (pain$ or disorder$ or dysfunction$)).mp. [mp=title, abstract, heading word, 
table of contents, key concepts] 
6. (atypical and odontol$).mp. 
7. (atypical and toothache$).mp. 
8. (atypical and “tooth pain”).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
9. “phantom tooth pain”.mp. 
10. (atypical and “facial pain”).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
11. (atypical and “facial neuralgia”).mp. [mp=title, abstract, heading word, table of contents, key 
concepts] 
12. or/1-11 
13. exp BEHAVIOR THERAPY/ 
14. PSYCHOTHERAPY/ 
15. AUTOGENIC TRAINING/ 
16. exp COUNSELING/ 
17. SOCIAL SUPPORT/ 
18. (“behaviour therap$” or “behaviortherap$”).mp. [mp=title, abstract, heading word, table of 
contents, key concepts] 
19. counsel$.mp. 
20. “autogenic train$”.mp. 
21. (psychotherap$ or psychoanal$).mp. [mp=title, abstract, heading word, table of contents, 
key concepts] 
22. (“self-help group” or “self help group” or communicat$ or educat$ or inform$).mp. [mp=title, 
abstract, heading word, table of 
contents, key concepts] 
23. or/13-22 
27. 23 and 12 
 
The above subject search was linked to the Cochrane Oral Health Group filter for PsycINFO via 
OVID: 
1. exp clinical trials/ 
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5. ((randomised adj controlled adj trial$) or (randomized adj controlled adj trial$)).mp. 
6. (controlled adj clinical adj trial$).mp. 
7. (random adjallocat$).mp. 
8. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab. 
9. (control$ adj4 trial$).mp. 
10. (ANIMALS not HUMANS).sh. 
11. or/1-9 
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Randomised controlled trial conducted in: Sweden 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Swedish Dental Society and the Faculty of Odontology, Umed 
University, 
Sweden 
Trial identification number: Not stated 
 
Participants  
30 patients with resistant burning mouth syndrome (BMS) were divided at 
random into equal groups, the therapy group (TG) and the attention/placebo 
group (APG). 
The patients were odontologically and medically examined and treated according 
to the protocol for the management of patients with BMS, including complete 
anamnesis, general medical and odontological examination, laboratory 
investigation and an epicutaneous patch test. 
 
Intervention  
Therapy group (TG) - Phase 1: an introductory session consisting of a 
motivational input and an oral examination. The patients were given time to 
decide whether or not to participate in the study. Phase 2: evaluation of BMS 
intensity (pre-treatment). Phase 3: cognitive therapy (CT) for 12-15 sessions; one 
hour once a week. Phase 4: evaluation of BMS intensity and oral examination 
immediately after completed CT (post-treatment). Phase 5: evaluation of BMS 
intensity and oral examination 6 months after completed CT.(6-month follow-up). 
Attention/placebo (APG) - Phase 1: an introductory session consisting of a 
motivational input and an oral examination. The patients were given time to 
decide whether or not to participate in the study. Phase 2: evaluation of BMS 
intensity (pre-treatment). Phase 3: return visits 3 times during 12-15 weeks for 
evaluation of BMS intensity and oral examination. Phase 4: evaluation of BMS 
intensity and oral examination (post-treatment). Phase 5: evaluation of BMS 
intensity and oral examination 6 months later (6-month follow-up). 
 
Outcomes  
Intensity of burning mouth measures on a non-validated VAS ranging from 1 to 7 
(endurable to unendurable).  
Risk of bias 
Bias Authors judgement  Support for judgement 
 
Random sequence generation  Unclear risk Not mentioned. 
Allocation concealment  Unclear risk Not mentioned. 
 






All the patients evaluated their burning mouth 
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There were no drop-outs. 
Selective reporting (reporting bias) Unclear risk Only intensity measured as an outcome. 
Other bias High risk Use of non-validated scales to measure 
outcome. Also components of intervention not 
described making it difficult to assess what 
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Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Not stated 
Trial identification number: Not stated 
 
Participants  
23 were assigned to the intervention and 21  were assigned to the control group. 
Inclusion: participants had to have a primary diagnosis of myofascial pain in the 
masticatory muscles that was based on guidelines from the Research Diagnostic 
Criteria for Type 1a and Type 1b disorders and included a chief complaint 
originating from the masticatory muscles, pain complaint that had been present 
for longer than 1 month, and report of pain in response to palpation of 3 or more 
standard muscle sites. All participants were maintained on medications that they 
were taking prior to the initial evaluation, and initial medication usage was not 
altered by the treating dentists during the course of the study 
 
Intervention  
Physical self-regulation (PSR) versus standard dental care (SDC). Both 
interventions had 2 visits (50 mins) 3 weeks apart 
PSR - targeted 7 specific domains: monitoring and reducing muscle parafunction 
in the head and neck region, proprioceptive awareness training to improve 
symmetric head and neck posture, instructions for improving sleep onset, 
position oriented relaxation training, physical activity, nutrition/fluid 
management, and training in diaphragmatic breathing (n = 23) 
SDC - a flat-plane intraoral appliance. Patients were instructed to wear the splint 
at night and were provided with general information regarding etiology and self-
care strategies for managing myofascial pain (e.g. eat soft foods, relax the jaws 
during the day). Participants were then scheduled for a follow-up appointment in 
3 weeks for splint adjustment and reinforcement of the pain management 
procedures. Participants were also reminded about how to seek further care if 
they felt that the present protocol was not meeting their needs (n = 21) 
 
Outcomes  
Pain relief measured on VAS (0 to 100). Activity interference, physical 
examination (mouth opening, muscle pain, awareness of tooth contacts) and 
psychologic variables (affective distress, somatization, depression, anxiety, 
obsessive/compulsive, sleep dysfunction, fatigue).  
Risk of bias 
Bias Authors judgement  Support for judgement 
 
Random sequence generation  Low risk Random assignment was accomplished by 
the use of a table of random numbers 
Allocation concealment  Unclear risk Not mentioned. 
 






Only outcome assessment blinded - a 










This article is protected by copyright. All rights reserved. 
  
training in orofacial pain who was not 
aware of the treatment protocol to which 
each participant was assigned performed 
all initial dental evaluations and administered 
the self-report measures after the dental 
evaluations 





Subsequent data analyses of the initial 
physical and psychologic characteristics of 
those who dropped out of the study versus 
those who completed the study did not reveal 
any significant differences between the 
2 groups on measured variables obtained at 
the beginning of the study 
Selective reporting (reporting bias) Low risk Negative results have been reported. 
Other bias High risk Only included a specific patient group 
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Randomised controlled trial conducted in: Canada 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: National Health and Welfare grant NAHS 30-9625 and provincial 
government Youth Employment Program project 
Trial identification number: Not stated 
 
Participants  
7 were assigned to the dental splint and physiotherapy program, 7 were assigned 
to the relaxation program utilizing progressive muscle relaxation, biofeedback, 
and stress management techniques and 7 were assigned to the minimal treatment 
program involving transcutaneous electrical nerve stimulation. 
Inclusion: complaint of pain of at least 6 months duration; tenderness to palpation 
of masticatory muscles; limitation or deviation of jaw mobility; absence of 
radiographic evidence of pathology of the joint as would result from disease or 
trauma 
Exclusion:  Joint tenderness or joint sounds may or may not have been present, 
but were exclusionary criteria if they were the principal complaint or associated 
with an organic condition. Many of the individuals screened complained of 
clicking or crepitus in the temporomandibular (TM) joint, which was considered 




3 interventions compared each consisting of 8-weekly, 1-hour sessions 
accompanied by recommendations for 30 minutes of daily homework: 
Dental programme (DPT) - delivered by 2 dentists and 3 physiotherapists. 
Conservative physical intervention, incorporated the use of an occlusal splint and 
the provision of weekly physiotherapy sessions oriented to the masticatory 
system with hot/cold applications, postural corrections, the avoidance of chewy 
foods, and exercise for the jaw. Subjects were to practice jaw exercises 30 minutes 
daily Biofeedback enhanced progressive relaxation programme (BER) - tape 
recorded progressive muscle relaxation training program with EMG training. 
During sessions 6 to 8 biofeedback was provided while patient undertaking 
nonverbal puzzles. Homework consisted of 30 mins progressive muscles 
relaxation exercises using audio tape 
TENS - weekly subthreshold electrical stimulations. Homework consisted of 
30min rest period 
 
Outcomes 
Interincisal opening (dentists rating), pain to palpation (dentists rating on a 
Likert-Scale), global rating of worst pain during 3-weeks post-treatment (self-
reporting  on a Likert-Scale),), adjectival pain rating (McGill Pain Questionnaire), 
mean weekly frequency of pain (self-reporting ), mean weekly intensity of pain 
(self-reporting  on a Likert-Scale),), EMG measures also reported 
Notes For the meta-analysis, biofeedback was used as the intervention group and DPT as 
the control 




Authors judgement  
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Insufficient information with regard to 
blinding of outcome assessors. Blinding of 
participants/carers not feasible 
 





7/28 participants not included in analysis. 
Main reason given was time constraints. 
However, no detail regarding which groups 
the 7 had originally been allocated to 
 










No power calculations, numbers in each 
group were small and no information on 










This article is protected by copyright. All rights reserved. 






Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: NIDR 
Trial identification number: Not stated 
 
Participants  
95 were assigned to the cognitive behavioural intervention and 90 were assigned 
to the usual treatment (UT) group. 
Inclusion: participants had TMD with a self-report of facial ache or pain in the 
muscles of mastication, the TM joint, the region in front of the ear or inside the 
ear, other than infection.  
Exclusion: pain attributable to confirmed migraine or head pain condition other 
than tension headache; acute infection or other significant disease of the teeth, 
ear, eye, nose or throat; or history of significant or debilitating chronic physical or 
mental illness. Patients requiring emergency TMD treatment were also excluded 
from the study 
 
Intervention  
Cognitive behavioural therapy (CBT) (n = 95) versus usual treatment (UT) (n = 
90) CBT - brief with 2 group sessions, 2-hours long, spaced 1-week apart. A 
detailed manual and set of materials to provide information concerning the 
nature and typical course of TMD; biomedical and biobehavioral management of 
TMD; the relationships among jaw muscle fatigue, muscle tension, and the 
psychophysiologic aspects of stress; the basics of pain physiology with an 
emphasis on chronic pain; how to self-monitor TMD signs and symptoms; and an 
introduction to cognitive and behavioral pain and stress coping strategies. 
Patients learned and had an opportunity to briefly practice a progressive 
relaxation method and a simple physiotherapy exercise for jaw muscles. Delivered 
by dentists and psychologists 
UT - conservative and typically included use of flat-plane occlusal splints, non-
steroidal anti-inflammatory medications, passive and active range of jaw motion 
exercises, modification of parafunctional and/or dietary habits and regular use of 
cold and heat packs. No limitations on number of sessions 
 
Outcomes 
Characteristic pain, pain interference, maximum assisted mandibular opening, 
unassisted mandibular opening, SCL-90 depression, SCL-90 somatization, 
knowledge of TMD, post-treatment satisfaction 
Notes  




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
Unclear risk Block randomisation used but details not 
described. 
Allocation concealment (selection 
bias) 
Unclear risk Insufficient detail. 
 
Blinding (performance bias and 
 Outcome measurement blinded - quote: “All 
clinical and self-report data were gathered at 















Low risk dental hygienist examiners blind to the 
subjects original random assignment to the CB 
or UT study conditions.” 
 





Quote: “All subjects who dropped out from the 
study prior to completion of the 12-month 
follow-up were asked to complete an 
abbreviated questionnaire inquiring into the 
status of their pain and jaw function in order 
to allow intent to treat analyses of all subjects.” 





Power calculations included and attempts 
made to standardise delivery of intervention 
and rotate clinicians delivering it. Also 
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Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: NIDCR 
Trial identification number: Not stated 
 
Participants  
61 were assigned to the self-care intervention (SC) and 63 were assigned to the 
usual care (UC). 
Inclusion: self-report of facial ache or pain in the muscles of mastication, the TMJ, 
the region in front of the ear or inside the ear, or report of stiffness or other 
symptoms of discomfort in the same orofacial region for which usual care was 
prescribed by the clinic TMD specialist; RDC/TMD Axis II GCP score of 0, I or II-
Low; age 18 to 70 years.” 
Exclusion: pain attributable to confirmed migraine or head pain condition other 
than tension headache; acute infection or other significant disease of the teeth, 
ears, eyes, nose, or throat; or presence of significant or debilitating chronic 
physical or mental illness; necessity for emergency TMD treatment.” 
 
Intervention  
Self-care intervention (SC) (n = 61) versus usual care (UC) (n = 63) 
SC - components included: education on TMD, guided reading with structured 
feedback, relaxation and stress management training including training in 
abdominal breathing, general muscle relaxation methods, and specific methods 
for relaxation of head, neck, and masticatory muscles, stress management, self-
monitoring of signs and symptoms, development of a “Personal TMD Self-Care 
Plan”, supervised practice and reinforcement of dentist prescribed self-care 
treatments, maintenance and relapse prevention 
UC- conservative treatment included: physiotherapy, patient education 
concerning parafunctional oral behaviours, diet, nature of the condition, and 
rationale for treatment, medications including analgesics, muscle relaxants, and 
antidepressants, intraoral flat plane occlusal appliances 
 
Outcomes 
Characteristic pain intensity, pain-related activity interference, vertical jaw range 
of motion, number of extra-oral muscle palpations, SCL-90 depression, SCL-90 
somatization, number of dental visits, helpfulness and satisfaction 
Notes Usual care included aspects of education and counselling and one may argue that 
these are psychosocial. However, these are invariably delivered as part of 
intraoral occlusal plane therapy and the education associated with these is usually 
directed towards occlusal aetiologies for the condition rather than psychosocial 




Authors judgement  
 
Support for judgement  
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Blinding (performance bias and 
detection bias) All outcomes 
 
High risk 
Some outcome measures were self-reported 
but unsure whether examiners were blinded 





Participants asked to give minimum data 
on pain characteristics and drop-outs 
compared with those who participated 





Power calculation provided and delivery 
of intervention standardised using manual 
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Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: NIDCR 
Trial identification number: Not stated 
 
Participants  
59 were assigned to the comprehensive care (CC) and 58 were assigned to the 
usual treatment (UT). 
Inclusion: self-report of facial ache or pain in the muscles of mastication, the TMJ, 
the region in front of the ear or inside the ear; RDC/TMD Axis II GCP score of II-
High,III or IV; age 18 to 70 years.”  
Exclusion: pain attributable to confirmed migraine or head pain condition other 
than tension headache; acute infection or other significant disease of the teeth, 
ears, eyes, nose, or throat; debilitating physical or mental illness; necessity for 
emergency TMD treatment; inability to speak or write English.” 
 
Intervention  
CC - CBT-based programme for chronic pain adapted for TMD and included: 
behavioural/relaxation, cognitive coping, explanatory model, health care, 
personal plan, maintenance and relapse prevention 
UT- conservative treatment included: physiotherapy, patient education 
concerning parafunctional oral behaviours, diet, nature of the condition, and 
rationale for treatment, medications including analgesics, muscle relaxants, and 
antidepressants, intraoral flat plane occlusal appliances 
 
Outcomes 
Characteristic pain intensity, pain-related activity interference, ability to control 
pain, vertical jaw range ofmotion, number of extraoralmuscle palpations, SCL-90 
depression, SCL-90 somatization, helpfulness and satisfaction 
Notes  




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
Unclear risk Insufficient detail. 
Allocation concealment (selection 
bias) 
Unclear risk Insufficient detail. 
 
 





Outcomes blinded - quote: “All clinical baseline 
and follow-up study data collection were 
performed by calibrated and reliable clinical 
examiners not participating in the RCT and 
blinded to the study group to which patients 
were assigned.” 
 
Incomplete outcome data (attrition 
bias) 
Low risk Quote: “All patients who dropped out from the 
study prior to completion of the 12- month 
follow-up were asked to provide minimal data 
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All outcomes allow intent-to-treat analyses.” 
Selective reporting (reporting bias) Low risk Relevant outcomes covered. 
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Randomised controlled trial conducted in: Spain 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: The Spanish Ministry of Science and Technology and the 
Valencian Regional Government of Industry, University and Science. 
Trial identification number: Not stated 
 
Participants  
41 were assigned to the experimental group and 31 were assigned to the control 
group. 
Inclusion criteria: TMD muscular subgroup diagnosis (group 1 axis I diagnosis) 
following Research Diagnostic Criteria for Temporomandibular Disorders 
(RDC/TMD).The Intellectual ability to follow the evaluation process and 
psychologic intervention. To assess this, the patient’s fluency and ability to 
understand during the interaction with the doctor together with the diagnosis of a 
mental disability was considered. 
Exclusion criteria: abnormalities such as facial deformity, tumoral pathology, 
lesions of oral mucosa, signs of schizophrenia or other psychotic disorders. 
 
Intervention  
The objective of this study was to assess the efficacy of cognitive behavioural 
therapy including hypnosis in patients with TMDs with a muscular diagnosis. 
Participants were randomly assigned to two groups; the experimental group 
receiving 6 sessions of CBT programme and the control group. All patients 
received conservative standard treatment for TMD. Assessment for pain variables 
and psychologic distress were carried out pre-treatment, post treatment (3 
months after pre-treatment) and follow up (9 months after pre-treatment). 
 
Outcomes 
Number of painful points on pressure (RDC/TMD), pain frequency (painful days 
in past 2 months), self-medication frequency (days with self-medication use in 
past 2 months), subjective pain index (McGill Pain Questionnaire and MPQ), pain 
interference (MPI), pain severity (MPI), emotional distress (including sub 
dimensions anxiety, somatization and depression) (BSI). 
Notes  




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
Low risk Quote: “An external statistical program 
assigned a number (between 0 and 9,999) to 
the subject included in the research sample: In 
this case, when the number was between 0 
and 5,549, the patient was assigned to the 
experimental group, the rest (between 5,550 
and 9,999) to the control group, compensating 
for the expected drop-out rate of 25% in the 
experimental group.” 
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Allocation concealment  Unclear risk Not stated. 
 
Blinding (performance bias and 




Quote: “Outcome assessors were blinded.” 
 
Incomplete outcome data (attrition 
bias) All outcomes 
 
Low risk 
Quote: “3 drop-outs from right after inclusion 
were not analysed while others who provided 
data were included. ‘Furthermore, in the 
control group three patients withdrew (one 
after one session and two after three sessions) 
because they did not feel any benefit of the 
treatment. These patients completed 
questionnaires after their last session of 
treatment and were therefore included in the 
analysis.” 
Selective reporting (reporting bias) Low risk No evidence of selective reporting. 
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Randomised controlled trial conducted in: United States 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: National Institutes of health 
Trial identification number: Not stated 
 
Participants  
A total of 108 chronic TMD patients (seeking treatment for symptoms present at 
least 6 months) were evaluated and randomly assigned to one of four treatment 
conditions: biofeedback (n D 27), CBST (n D 24), combined biofeedback and CBST 
(n D 29), or no-treatment comparison (n D 28). 
Inclusion: all subjects were diagnosed as having TMD, using the RDC criteria.  
Exclusion criteria eliminated individuals with a significant physical condition such 
as cancer, low-back pain and fibromyalgia, people with six or more DSM-IV Axis I 
diagnoses, a diagnosis of psychosis or active suicidal ideation, and those who did 
not meet the RDC criteria. 
 
Intervention  
4 intervention groups: biofeedback (n = 27), CBT (n = 24), combined biofeedback 
and CBT (n = 29) versus usual care (n = 28) 
Biofeedback - 12 x 1-2 hour sessions. Standardized protocol developed by one of 
the authors who specialized in biofeedback and stress management techniques. 
The equipment consisted of ’AJ & J (Poulsbo, WA), Model M-57 EMG, and the J & J 
Model T-68 Temperature Biofeedback Units’. The 12 biofeedback sessions 
included relaxation training and 15 min of temperature and EMG biofeedback. 
The EMG biofeedback electrodes placement was over the frontalis muscles 
CBT - 12 x 1-2 hour sessions delivered by clinical psychologists. The protocol was 
a modified adaptation of a CBT programme for depression and aspects from other 
pain management programs were also integrated. Topics included a “rationale for 
skills training, relaxation training, distraction techniques, designing a self-change 
plan, pleasant activities scheduling, formulating a pleasant activity plan, cognitive 
restructuring, self-instructional training, social skills training including 
assertiveness, maintenance of skills, and the development of a life plan”. 
Education of stress and relationship to anxiety, depression and pain was deployed 
Combined CBT and biofeedback - the combined treatment protocol was a 
combination of components from the above protocols. While there was some 
overlapping of material, such as relaxation training, social learning 
conceptualizations, and maintaining social skills, the 12 sessions for the combined 
intervention required extra time (approximately 2.5 versus 2 hrs) 
Usual care - “standard nonsurgical dental care-only group (e.g. treatment 
involving splints, medication, physical therapy, etc) that controlled for therapeutic 
contact and expectancy in terms of going through comprehensive biopsychosocial 
evaluations and questioned about any therapeutic improvements”. Number of 
sessions not stated 
 
Outcomes Pain (CPI), disability (GCPS) and limitation in mandibular functioning (a brief 12-
item checklist). 
Notes Workbooks, reading, homework between sessions. 
Sessions carried out in sequence order (even if a session missed) 
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Follow-up of Mishra 2000; original study based on n = 84. 




Authors judgement  
 
Support for judgement  
 




The urn method of randomisation was used 
which was defined as “a semi random 
procedure to maintain demographic variables 
and chronic TMD type (i.e. RDC Axis I 
physiological diagnostic subgroups) 
comparable among the treatment groups” 
Quote: “Method promotes ongoing balance 
among groups for possible mediating/ 
confounding variables; in this study these 
were gender, age, race, initial pain severity, 
RDC Axis I diagnosis, and DSM-IV diagnosis.” 
 






Blinding (performance bias and 






Incomplete outcome data (attrition 
bias) All outcomes 
 
Low risk 
The analysis was weighted by the number of 
weeks the subject came to treatment. 
The no-treatment group was only scheduled 
for a pre- and postevaluation, so those subjects 
received a weighting of either a 0 (if they did 
not have a postevaluation) or a 12 (if they did 
have a postevaluation). 
However, because all no-treatment group 
subjects had pre- and post-treatment 
evaluations, only the weighting factor of 12 
was used. Planned pair wise contrasts were 
conducted to compare the groups to one 
another. 
 










The combined biofeedback and CBT arm 
had longer sessions than the other two arms 
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Randomised controlled trial conducted in: United States 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: National Institutes of health 
Trial identification number: Not stated 
 
Participants  
56 were assigned to the early intervention which included individual CBT/BFB 
and 45 were assigned to the control group.  
Inclusion: adults aged 18 to 70 years who had acute jaw or facial pain that had 
been present for less than six months.  
Exclusion: subjects if they had a comorbid pain-exacerbating physical condition 




Early CBT intervention (n = 54) versus non-intervention control (NI) (n = 45) 
CBT - 6 x 1 hr audiotaped face to face sessions based on previous studies by 
Gardea 2001. 
• CBT programme for depression used for CBT 
•Education (mind-body relationship to stress and body’s reaction to stress) 
• Relaxation training 
• Distraction and pleasant activity scheduling 
• Cognitive restructuring 
• Self-instruction training 
• Maintenance of skills 
• Biofeedback delivered to frontalis muscles 
NI - although treatment not stated authors include a statement “During the entire 
study, we encouraged all of the subjects, even those in the NI group, to continue 
treatment as usual with their outside health care providers if needed; we 
provided no other advice”. The types of health care provider consulted by the NI 
group consisted of chiropractor (13.6 visits), dentist (34.8 visits), massage 
therapist (13.0 visits), physician (7.6 visits) , medical technician (0.5 visits), oral 
surgeon (7.1 visits), orthodontist (8.0 visits) and physical therapist (7.7 visits). 
This suggests that the treatments for this group included a combination of splints, 




Pain, depression, ways of coping. Measures included a shortened version of the 
RDC evaluation, BDI-II, the ways of coping, the SCID-I and SCIDII, and a pain 
intensity measure (CPI). 
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Random sequence generation 
(selection bias) 
 
Authors judgement  
 
Support for judgement  
Allocation concealment (selection 
bias) 
Unclear risk Not stated. 
Blinding (performance bias and 
detection bias)All outcomes 
Unclear risk Not stated. 
Incomplete outcome data (attrition 
bias) All outcomes 
 
High risk 
Only one assessor used to measure outcomes 
due to scheduling problems and not 
clear whether blinded 
 
Selective reporting (reporting bias) 
 
Low risk 
Quote: “To manage missing data, we 
used the last-observation-carried-forward 
approach in which missing values are replaced 
with the last previous non-missing value. We 
found no statistical differences between those 
subjects who completed the one-year follow-
up (n = 98) and those who did not (n = 3).” 




Only one assessor used to measure outcomes 
due to scheduling problems and not clear 
whether blinded. Also, the intervention 
group has a greater number of visits 
to a chiropractor, massage therapist and 
acupuncturist compared with the non-
intervention group and this was not adjusted 
for in the analysis and may suggest that 
these additional interventions may explain 
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Randomised controlled trial conducted in: UK, TMD and oral medicine clinics of 
the University of Manchester Dental Hospital and the maxillofacial outpatient 
clinic at North Manchester General Hospital and Salford Royal NHS Trust 
Number of centres: 1 
Recruitment period: Not stated 
Funding source:  Clinician Scientist Award by the NIHR (cs/2008/08/001) 
Trial identification number: Not stated 
 
Participants  
19 were assigned to the intervention group and 18 were assigned to the usual 
treatment. 
Inclusion criteria: Adults aged 16 and over, Those who are suffering from 
persistent pain in their face or mouth for 3 months or longer, sufficient level of 
English to complete questionnaires and take part in the guided self-help therapy 
Exclusion Criteria: Current treatment with a psychological therapy for oral or 
facial pain, Current suicidal ideation (assessed at baseline by the Patient Health 
Questionnaire (PHQ-9), Commencement of a prescribed dose of antidepressants 
less than 3 months prior to the recruitment date 
 
Intervention  
Objective of study was to compare treatment with self-guided help against usual 
treatment. They were randomized into either the intervention group or the usual 
treatment (control) group 
Intervention was delivered through manual guided self-help 
(https://www.click2go.umip.com/i/coa/chronic_orofacial_pain_manual.html) by 
presenting a series of four steps, starting with understanding and legitimizing 
chronic orofacial pain by using patient experiences and stories and continuing 
with three further steps on goal setting, choosing the intervention, and 
techniques. The manual also included recovery stories to illustrate the techniques 
described. Techniques focused on three cognitive behavioural interventions: 
lifestyle changes (managing sleep, irritability, fatigue, and other unhelpful habits; 
eg, teeth clenching), behavioural activation (increasing or decreasing activities, 
choosing a balance of routine pleasurable and necessary activities during the 
week), and cognitive restructuring (identifying and evaluating unhelpful thinking 
styles). 
Usual care comprised oral splints, pharmacologic treatment, or counselling and 
education. These were provided alone or in combination. 
Validated outcome measures were used to measure the potential effectiveness of 
the intervention over a number of domains, physical and mental functioning, 
anxiety and depression, pain intensity and interference with life, disability, and 
illness behaviour. Bootstrap confidence intervals were computed for the 
treatment effect post treatment and at three months follow up. 
 
Outcomes 
Physical and mental functioning (SF36), anxiety and depression (HADS), pain 
intensity and interference with life (BPI), disability (MOPDS), illness behaviour 
(IPQr). 




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
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Allocation concealment (selection 
bias) 
Low risk Minimization randomization 
 
Blinding (performance bias and 
detection bias) All outcomes 
Low risk Single blind (impossible to blind patients due 
to the nature of the treatment but the research 
who was blind to allocation collected follow up 
data) 
 
Incomplete outcome data (attrition 





Selective reporting (reporting bias) Low risk No evidence of selective reporting  
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Randomised controlled trial conducted in: Japan 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Not stated 
Trial identification number: Not stated 
 
Participants  
20 were assigned to the CB intervention (IT-1), 20 were assigned to the CB 
intervention with a posture correction in daily life (IT-2). And 20 were assigned to 
the non-intervention control group (CT). 
Inclusion: myofascial pain with limited opening (MLO) was defined as “Pain of 
muscle origin, including a complaint of pain as well as pain associated with 
localized areas of tenderness to palpation in muscle. Report of pain or ache in the 
jaw, temples, face, preauricular area, or inside the ear at rest or during function; 
pain reported by the subject in response to palpation of three or more of the 
following 20 muscle sites (right side and left side count as separate sites for each 
muscle): posterior temporalis, middle temporalis, anterior temporalis, origin of 
masseter, body of masseter, insertion of masseter, posterior mandibular region, 
submandibular region, lateral pterygoid area, and tendon of the temporalis. At 
least one of the complaints of pain; plus 3. Pain-free unassisted mandibular 
opening of less than 40 mm; plus 4. Maximum assisted opening (passive stretch) 
of 5 mm or greater than, pain-free, unassisted opening.” Exclusion criteria: 
“Patients who have already been treated at other clinics for TMD. 
Exclusion: patients who have obvious occlusal interference or prostheses of broad 
area. History of orthodontic treatment. Metabolic disease (e.g. diabetes, 
hyperthyroidism). Neurological disorders (e.g. dyskinesia, trigeminal neuralgia). 
Vascular disease (e.g. migraine, hypertensions). Neoplasia. History of drug abuse. 
Recent facial or cervical trauma (e.g. whiplash). Patients assigned to categories III 
and IV or answered ‘yes’ to the questionnaire under psychiatric disorders on the 
Cornell Medical Index. Patients currently receiving medication or other treatment 
that could not be interrupted for the study.” 
 
Intervention  
Cognitive behavioural (CB), CB with posture correction versus non-intervention 
control group; 20 in each group CB - was carried out in accordance with Dworkin 
1994 i.e. information concerning the nature and typical course of MLO; biomedical 
and biobehavioural management of MLO; the relationship among jaw muscle 
fatigue, muscle tension, and the psychophysiologic aspects of stress; the basics of 
pain physiology with an emphasis on chronic pain; how to self-monitor MLO signs 
and symptoms; and an introduction to cognitive and behavioural pain and stress 
coping strategies. Patients learned and had an opportunity to briefly practice a 
progressive relaxation method for the jaw muscles. The patients were given these 
instructions at each monthly appointment for 12 months CB with posture 
correction - in addition to the above subjects were asked to do the following: 
“(A) Sitting: Don’t slouch when sitting on a chair and don’t sit with your legs 
crossed. Don’t rest your chin in your hand. If you sit on a floor, sit upright by 
sitting on your folded legs 
(B) Standing: Rest your weight on your both feet evenly, and don’t lean against a 
wall 
(C) Sleeping: Using a hard mattress or futon, lie on your back, keeping your neck 
straight with a low pillow or flattened towel 
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Masticate 
looking straight ahead and not downward 
(E) Walking: Walk with long strides while swinging your arms 
(F) Others: Don’t carry a heavy package with one hand. Don’t thrust your head 
forward.” 
Non-intervention control group were given generalised instructions emphasising 
painless jaw use during normal activity and restriction of some specific jaw 
activities such as extreme opening or chewing hard foods 
Outcomes Pain-free unassisted mouth opening (one decimal point by the examiner using 
slide callipers to measure right or left inter-incisal distance added to values of 
overbite), pain intensity (100mm VAS), disturbance in daily life. 
Notes  




Authors judgement  
 
Support for judgement  
 





Random allocation - details not described. 
Allocation concealment (selection 
bias) 
High risk Not described. 
Blinding (performance bias and 
detection bias) All outcomes 
High risk Not described. 
Incomplete outcome data (attrition 
bias) All outcomes 
High risk No reasons given for drop-out. No intention- 
to-treat analysis conducted 
Selective reporting (reporting bias) High risk Detail missing when presenting findings. 
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Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: October 2003 to July 2007 
Funding source: NIDCR and NIH 
Trial identification number: Not stated 
 
Participants  
52 were assigned to the standard treatment plus cognitive-behavioural skills 
training group, and 49 were assigned to the standard treatment.  
Inclusion: patients needed to have a positive Axis I diagnosis on the Research 
Diagnostic Criteria (RDC) for temporomandibular disorders (positive on at least 
one symptom-based group), and could have no contraindications to TMD 
treatment (as determined by the consulting oral surgeon). 
Exclusion criteria: lack of fluency in English (as determined by inability to read 
and understand a statement of informed consent); previous surgery for treatment 
of TMD pain; history of rheumatoid disease; extensive anatomical destruction or 
deterioration of the TM joint; diagnosed as having pain of neuropathic or 
odontogenic origin; carrying a diagnosis of psychosis; current use of 
antidepressants or anxiolytics; taking opioid pain medication; or pregnancy (due 




Standard treatment (STD) condition entailing the placement of a flat-plane 
disoccluding splint, the prescription of non-steroidal anti-inflammatory drugs, 
and instruction for a soft diet  
Standard treatment plus CBT condition (STD + CBT) in which patients received all 
elements of STD, but also received cognitive-behavioural coping skills training. 
Each treatment was 6-weeks long 
 
Outcomes 
Pain intensity (MPI), characteristic pain intensity, Depression: 20-item CES-D, 
activity Interference (MPI). 
Notes  




Authors judgement  
 
Support for judgement  
 




Computerised urn randomisation procedure. 
The two arms were balanced on gender, age, 
ethnic background, pain level recorded at 
baseline, and RDC Axis I diagnoses 
Allocation concealment (selection 
bias) 
High risk Participants informed of their treatment 
assignments. 
 
Blinding (performance bias and 
detection bias) All outcomes 
 
High risk 
Pretreatment and follow-up assessments 
conducted by a research associate who was 
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Of 196 persons screened, 121 were deemed 
eligible for the study, and 101were assigned to 
treatment. At post-treatment 88%of patients 
provided data, and 73% provided data at 52 
weeks. Losses to follow-up were 
equivalent across treatment conditions 





Power calculation included - quote: “This 
number of participants was sufficient to, at a 
minimum, detect significant between group 
differences at post-treatment on each of the 
major dependent variables, with a power of .8 
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Randomised controlled trial conducted in: Germany 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Not stated 
Trial identification number: Not stated 
 
Participants  
29 were assigned to the biofeedback-based cognitive behavioural treatment and 
29 were assigned to the dental treatment with occlusal splint.  
Inclusion: a painful axis I TMD diagnosis according to the Research Diagnostic 
Criteria for Temporomandibular Disorders (RDC/TMD), in other words group I 
(myofascial pain), or group III (arthralgia, arthritis, arthrosis) or both; patients 
could also have a group II diagnosis (disk displacement), but a painless group II 
diagnosis was not sufficient for study inclusion; pain present for at least 3 
months; age between 18 and 70. 
Exclusion: presence of an OS already matching to our standards, for example an 
OS as described below (patients could be included if they currently used a splint 
that did not meet our standards, such as a non-OS); need for further diagnostic 
investigation or need for dental/maxillofacial treatment, as judged by a 
specialized dentist; other major chronic pain conditions predominant in disability, 
for example chronic low back pain or headache, as assessed in the diagnostic 
interview; major medical or psychiatric conditions that would interfere with the 
ability to participate. 
 
Intervention  
Aim of the study was to assess the efficiency of Bio feedback based cognitive-
behavioural treatment (BFM-CBT) versus the occlusal splint therapy (OS). In 
addition changes in nocturnal masseter muscle activity (NMMA) was also 
investigated.  
Participants were randomly assigned to two groups 1) those who received eight 
weekly sessions of BFB-CBT 2) those who received OS treatment. Primary 
outcome measures were based on changes in pain intensity and disability. 
Secondary outcomes included emotional functioning, pain coping, somatoform 
symptoms, treatment satisfaction, and adverse events. NMMA was assessed 
during 3 nights pre-treatment and post treatment with portable devices. 
Follow up assessments was caries out 6 months after the treatment. 
 
Outcomes 
Characteristic pain intensity was calculated by averaging ratings of current pain, 
average pain, and worst pain in the past month on a numeric rating scale from 0 
to 10, as recommended by RDC/TMD.  Pain-related disability (PDI).  Jaw use 
limitations (JDL) from the RDC/TMD.  Depressive symptoms ( CES-D).  General 
anxiety symptoms (GAD-7).  Cognitive and behavioral pain coping strategies 
(FESV).   Somatoform complaints during the past week (SOMS-7.)  TMD-related 
symptoms, such as jaw pain, toothache, or dizziness (a 41-item TMD symptom 
list).  Participant ratings of global improvement (PGIC).  Satisfaction with 
treatment (a 13-item rating scale adapted from a randomized controlled trial for 
chronic tinnitus). 
Notes  
Risk of bias 
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Bias Authors judgement  Support for judgement  
Random sequence generation 
(selection bias) 
Low risk Quote: “Random assignment to conditions was 
generated by a researcher not involved in the 
study with the use of randomization software 
(GraphPad Software Inc., La Jolla, CA), and 
assignment was concealed in closed 
envelopes.” 
 




Quote: “Random assignment to conditions was 
generated by a researcher not involved in the 
study with the use of randomization software 
(GraphPad Software Inc., La Jolla, CA), and 
assignment was concealed in closed 
envelopes.” 
Blinding (performance bias and 
detection bias) All outcomes 
Low risk Quote: “Assessor blinded.” 
Incomplete outcome data (attrition 
bias) All outcomes 
Low risk Quote: “ITT used for dropouts.” 
Selective reporting (reporting bias) Low risk No evidence of selective reporting  
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Randomised controlled trial conducted in: United states 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Not stated 
Trial identification number: Not stated 
 
Participants  
10 were assigned to the treatment group and 10 were assigned to the wait-list 
control group. 
Inclusion: report of pain in temporomandibular joint or surrounding musculature 
in the past year; plus one of following: a) locked jaw, b) mandibular joint sounds, 
c) stiffness, tenderness or tightness in jaw, d) pain in ears, temple or cheek, e) 
uncomfortable bite; 18 to 55 years of age; access to email or telephone. 
Exclusion: head or facial surgery; diagnosis of degenerative joint disorder; 
currently taking psychotropic medication; pregnancy. 
 
Intervention  
Habit reversal treatment with minimal therapist contact (n = 10) versus waiting 
list control (n = 10). Both interventions lasted 20 weeks 
Habit reversal - 7-lesson manual appropriate for a self-help format: 
Lesson 1 included an overview and rationale for treatment including the role of 
stress and oral habits in facial pain. Individuals were introduced to the concept of 
identifying, detecting and recording oral habits and given specific exercises to 
practice doing so Lesson 2 included awareness training exercises, including deep 
breathing and a structured oral habits diary was introduced 
Lesson 3 involved learning to use facial exercises and deep breathing as 
competing responses for oral habits. The content of the oral habits diary was 
reviewed and elaborated on in order to detect life situations where oral habits are 
likely to occur  
In lesson 4 the exercises from previous lessons continued and progressive muscle 
relaxation exercises were introduced via written materials and audiotape. 
Exercises and examples of how to develop individually and situationally specific 
incompatible behaviours were provided and negative practice as an awareness 
training exercise was introduced 
 In lesson 5 practice exercises for simulating the use of the various habit 
interruption and reversal exercises were introduced and the use of negative 
practice for nocturnal bruxing was reviewed  
Lesson 6 added a visualisation exercise and a shorter version of the relaxation 
training exercise to enhance participant’s awareness of changing levels of muscle 
tension caused by oral habits  
In the final lesson participants reviewed the previous exercises, emphasising 
again the need to practice skills they had learned. An extensive discussion of 
relapse prevention and how to prevent relapses was also presented. Throughout 
the treatment participants reviewed difficulties applying techniques during the 
previous week. The use of positive self-statements and contingent rewards for 
implementing the exercises was emphasised. Each lesson included a review of the 
previous lesson, troubleshooting, goal setting, and record keeping components 















Mean weekly pain rating (from pain diary), highest pain intensity rating for week 
(from pain diary), number of pain-free days (from pain diary), maladaptive oral 
habits (oral habits questionnaire), life interference (MPI), stress (Hassles scale) 
Notes Highest pain intensity rating for week (from pain diary). 




Authors judgement  
 
Support for judgement  
 




Quote: “The two conditions (treatment 
and control) were assigned numeric values 
prior to participant recruitment and a random 
number table was consulted to determine the 
order of assignment. Participants were 
randomly assigned to condition via blocked 
randomization utilizing blocks of two.” 
Allocation concealment (selection 
bias) 
High risk Block randomisation. Following drop-out, 
next person allocated to space left 
 
Blinding (performance bias and 
detection bias) All outcomes 
 
Unclear risk 
Quote: “The therapist was naive to group 
assignment until after the treatment 
orientation, at which time the therapist 
referred to the random assignment list and 
assigned the participant to the next available 
position. The therapist then presented 
condition- specific information (e.g., when they 
would receive their first lesson or how long 
they could anticipate waiting for treatment to 
begin).” 
 
Incomplete outcome data (attrition 
bias) All outcomes 
 
High risk 
No follow-up of drop-out data. 
Quote: “Missing data at post-treatment 
analysed using last observation carried 
forward (i.e. score at baseline)” 
Selective reporting (reporting bias) Unclear risk Not enough detail. 
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Randomised controlled trial conducted in: US 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: Not stated 
Trial identification number: Not stated 
 
Participants  
30 were assigned to the interocclusial appliance (IA) group, 30 were assigned to 
the biofeedback /stress management treatment group, and 20 were assigned to a 
6-week awaiting list control group. 
Inclusion: pain and tenderness of the muscles of mastication and TMJ region; 
limited mandibular movements of at least 2 months; at least 18 years of age. 
Exclusion: no evidence of serious psychopathology (not operationalised); no 
history of TMJ related surgery. 
 
Intervention  
Interocclusial appliance (IA) (n = 30) versus biofeedback (BF) and stress 
management(SM) (n = 30) versus waiting list controls (n = 20). All interventions 
lasted 6 weeks  
IA - flat heat-cured acrylic resin splint constructed on the maxillary or mandibular 
arch. Patients instructed to wear at all times (except eating/dental hygiene). 
Weekly sessions included instruction in oral habits. Review and adjustment of IA 
BF/SM - biofeedback (compute controlled tone and pulsating feedback 
proportionate to masseter muscle tension levels) 
Stress management included: i) didactic education on link between stress, muscle 
tension and pain; ii) training in cognitive coping skills e.g. attention diversion; iii) 
homework in relaxation skills  
Waiting list controls - “Patients assigned to the WL group received the same 
pretreatment assessment procedures as the IA and BF/SM groups. At the time of 
the pretreatment evaluation, WL patients were informed that there was a waiting 
list for treatment and were scheduled for a second appointment 6 weeks later.” 
Outcomes Pain (PSS from the MPI, PPI), depression (CES-D and POMS), credibility rating for 
patients in the active treatment groups (a set of five 10-point scales developed by 
Borkovec and Nau). 
Notes Comparison for this paper in the review was between the BF/SM group as 
intervention and IA group as control 




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
Unclear risk Not stated. 
Allocation concealment (selection 
bias) 
Unclear risk Not enough information. Consecutive referrals 
were recruited. Random assignment 
to IA versus BF/SM versus waiting list control 
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detection bias) All outcomes 
 
Incomplete outcome data (attrition 
bias) All outcomes 
High risk No detail provided of numbers of excluded 
individuals. 
Selective reporting (reporting bias) Unclear risk Insufficient detail. 
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Randomised controlled trial conducted in: United States 
Number of centres: 1 
Recruitment period: Not stated 
Funding source: National Institute Dental Research, National Institutes of Health 




24 were assigned to a combination of IA (i.e., a flat occlusal splint), SM plus SC (IA 
+ SM + SC) and 24 were assigned to IA and SM plus CT for depression (IA + SM + 
CT). 
Inclusion: pain and tenderness of the muscles of mastication and TMJ region and 
restricted mandibular opening of 3-months duration or longer; no evidence of 




A combination of IA, SM plus SC (IA + SM + SC) (n = 22) versus IA + SM + CT (n = 
23) IA = intraoral appliance; SM = stress management with biofeedback; SC = 
supportive counselling; CT = cognitive therapy. Therefore the comparison was 
between CT and SC 
IA + SM- “All patients received a standardized 6-week treatment program that 
combined an IA and SM, previously demonstrated to be effective in treating TMD 
(Turk 1993). The IA treatment component consisted of a full-arch, flat, acrylic 
resin splint and was constructed on the maxillary or mandibular arch. This 
treatment component was delivered by two prosthodontists trained in TMD 
treatment.” 
The SM treatment component consisted of 6weekly sessions conducted by a 
psychologist trained in biofeedback-assisted relaxation procedures and stress 
management treatment of TMD patients. Biofeedback involved electrodes over 
the masseter muscle and computer- controlled auditory tone and pulsating 
feedback directly proportionate to masseter muscle tension levels. “In addition to 
biofeedback, the SM protocol also included (a)didactic education regarding the 
association between stress, increased muscle tension, and pain; (b) information 
and training in the use of cognitive coping skills (e.g. attention diversion) to 
control pain; (c) training in a progressive muscle relaxation exercise; and (d) 
homework assignments to help patients practice relaxation skills without the 
biofeedback instrumentation.” 
CT group received standardised CT for depression. “This treatment focused on the 
identification of cognitive distortions or maladaptive thoughts regarding events 
that increased feelings of helplessness, hopelessness, and limited self-control. 
Strategies, individualized to the patient’s unique circumstances were developed to 
help the patient eliminate or reduce these maladaptive cognitions, thereby 
reducing negative affect in response to life events.” 
SC - this was delivered by a therapist whose role was “to provide unconditional 
and non directive support as the patient discussed general life stressors. Thus, 
time and attention from the therapist was consistent across treatment conditions, 
as was the opportunity to communicate in general about stressors. Although 
patients in this treatment protocol were given the opportunity to discuss 
stressors, cognitive distortions were not challenged, and they were not taught 














4 physical measures were used and included: (a) a muscle palpation pain index, 
an aggregate of the number of painful muscle sites, based on the bilateral 
examination of the 10 muscle sites recommended in the RDC; (b) a TMJ palpation 
pain index, an aggregate of the number of painful responses, based on the specific 
joint palpation sites recommended in the RDC for TMD; (c) unassisted mandibular 
opening without pain; and (d) maximum unassisted mandibular opening 
Other measures included: McGill pain questionnaire, BDI, pain catastrophising 
scale (CSQ), interference scale (MPI), oral-parafunctional habits scale, self-
reported use of medication, self-reported use of health care resources for TMJ 
pain 
Notes Difficult to decipher components as there were many i.e. 3 interventions and then 
components of the 3 interventions 




Authors judgement  
 
Support for judgement  
Random sequence generation 
(selection bias) 
Unclear risk Not mentioned. 
 
Allocation concealment (selection 
bias) 
Unclear risk Not mentioned. 
Blinding (performance bias and 
detection bias) All outcomes 
Unclear risk Not mentioned. 
Incomplete outcome data (attrition 
bias) All outcomes 
High risk No intention-to-treat analysis reported. 
Selective reporting (reporting bias) Low risk Nothing that suggests selective reporting. 
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Randomised controlled trial conducted in: United States 
Number of centres: 1 
Recruitment period: 2001-2004 
Funding source: NIDCR 
Trial identification number: Not stated 
 
Participants  
79 were assigned to the cognitive-behavioural therapy and 79 were assigned to 
the education/attention control condition. 
Inclusion: age 18 years or older; an RDC/TMD Axis I TMD diagnosis made by an 
oral medicine specialist based on a structured RDC/TMD clinical examination; 
residence within a 2-hr drive of the TMD clinic; facial pain for at least 3 months; 
facial pain-related disability, as defined by a chronic pain grade of II high, III, or 
IV; ability to communicate in English. 
Exclusion: (assessed by the patient’s oral medicine specialist and the study 
coordinator) needed for further diagnostic evaluation; pending litigation or 
disability compensation for pain; current or previous CBT for pain; and major 
medical or psychiatric conditions that would interfere with ability to participate. 
Interventions CBT and education/attention - 4 sessions with 15mins phone calls between 
sessions and further calls 2,4,8,12,16,20 and 24 weeks after fourth session. 
Usual treatment - All study participants received treatment as usual from their 
dentist at the Orofacial Pain Clinic. These treatments were conservative and 
typically included instruction in jaw posture monitoring and correction (including 
instruction to keep jaws relaxed and teeth apart, but no training in muscle 
relaxation techniques), advice to apply heat and/or cold to painful facial areas, 
and recommendations concerning diet modifications. Medications (e.g., non-
steroidal anti-inflammatory drugs), jaw stretching exercises, and occlusal splints 
were prescribed for some patients. 
 
Outcomes 
Activity interference (GCPS, CPI), jaw use limitations (MFIQ), depression (BDI), 
process measures pain beliefs (SOPA, TMD SES), pain catastrophizing (CSQ, PCS), 
pain coping (CPCI), treatment credibility, TMD knowledge, treatment helpfulness 
Notes Results displayed in the paper are shown as a total % effect explained by various 
mediators on: activity interference, pain intensity, masticatory scores, non-
masticatory scores with CBT, as no significant effect was found for CBT versus 
attention and education 




Authors judgement  
 
Support for judgement  
 




Quote: “Randomization assignments were 
generated by a biostatistician (LM) using 
randomly selected block sizes of two or four 
using the sample function of the S-PLUS 
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Seattle, WA) to prevent determination of 
the treatment assignment” 
 




Treatment assignments were recorded on slips 
of paper numbered consecutively within each 
stratum and sealed in envelopes sequentially 
numbered by stratum. Randomisation 
assignment was concealed to all study 
personnel until envelopes were opened by 
research staff after subject consent was 
obtained. 
 
Blinding (performance bias and 




Outcome measures were self-reported so 
outcomes blinded. 
 
Incomplete outcome data (attrition 




Followed up at telephone calls or next session. 
 




Insignificant results reported. 
 
Other bias 
 
Unclear risk 
 
Insufficient detail. 
